Singapore, Singapore

Noah Riandiputra Sundah

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: National University of Singapore. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noah Riandiputra Sundah. Retrieved from https://idiyas.com/inventor/noah-riandiputra-sundah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noah Riandiputra Sundah: Inventor in Molecular Detection

Introduction

Noah Riandiputra Sundah is an inventor based in Singapore, SG, associated with the National University of Singapore. His patent work includes a molecular approach for detecting SARS-CoV-2.

Latest Patents

Sundah is listed as an inventor on 1 patent: “Catalytic Amplification by Transition-State Molecular Switches for Direct and Sensitive Detection of SARS-CoV-2.” The invention describes a method designed to amplify molecular signals to support sensitive, direct detection of the virus.

Career Highlights

Sundah’s listed patent reflects work at the intersection of molecular technology and diagnostic detection. His association with the National University of Singapore connects this invention to the university’s research environment.

Collaborations

The patent’s listed collaborators include Huilin Shao and Auginia Natalia. Their shared work brings together contributors on a molecular detection approach for SARS-CoV-2.

Conclusion

Noah Riandiputra Sundah’s patent record highlights an invention focused on transition-state molecular switches and sensitive SARS-CoV-2 detection.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…